Condition Archives - Page 36 of 132

Prevention of Glucocorticoid-Induced Osteoporosis

Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis and a significant cause of morbidity among patients receiving long-term corticosteroid therapy. Effective prevention…

prevention of fetal neural tube defect during pregnancy

Condition P

Prevention of Fetal Neural Tube Defects During Pregnancy

Fetal neural tube defects (NTDs) are serious congenital malformations that arise during early embryonic development, commonly manifesting as spina bifida or anencephaly. Preventive strategies play…

Condition P

Prevention of Disseminated Candidiasis

Disseminated candidiasis, a severe and potentially life-threatening systemic fungal infection caused primarily by Candida albicans and other non-albicans species, presents a significant challenge in hospitalized…

Condition P

Prevention of Deep Vein Thrombosis Recurrence

Recurrent deep vein thrombosis (DVT) presents a significant risk of morbidity and mortality. Once a patient experiences an initial episode, the likelihood of recurrence is…

Condition P

Prevention of CMV Disease After Organ Transplantation

Cytomegalovirus (CMV) is a major cause of infectious complications following solid organ transplantation. Its presence not only results in direct effects—such as CMV syndrome and…

Condition P

Prevention of CMV Disease After Kidney Transplantation

Cytomegalovirus (CMV) remains one of the most significant viral infections in renal transplant recipients. CMV infection following kidney transplantation not only causes direct disease but…

Condition P

Prevention of CMV Disease After Cardiac Transplantation

Cytomegalovirus (CMV) is the most common opportunistic infection following cardiac transplantation. It is associated with direct effects such as CMV syndrome and tissue-invasive disease, as…

Condition P

Prevention of Cisplatin-Induced Ototoxicity

Cisplatin remains a cornerstone chemotherapeutic agent for treating various solid tumors, including testicular, ovarian, head and neck, and lung cancers. However, its clinical efficacy is…

Condition P

Prevention of Chemotherapy-Induced Neurotoxicity

Chemotherapy-induced neurotoxicity, particularly peripheral neuropathy, is a frequent and often dose-limiting complication of cancer treatment. This form of neurotoxicity primarily affects sensory nerves and is…

Condition P

Prevention of Chemotherapy-Induced Mucositis

Chemotherapy-induced mucositis is a debilitating inflammatory condition of the mucosal lining of the gastrointestinal tract, most commonly manifesting in the oral cavity. It significantly compromises…